Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [3746]

EMCC 2011: Phase II study shows new cancer drug combination significantly delays breast cancer progression

EMCC 2011: Phase II study shows new cancer drug combination significantly delays breast cancer progression

Virus shows promise as cancer treatment

Virus shows promise as cancer treatment

Immunity: the motor that moves the body's defences

Immunity: the motor that moves the body's defences

Inflammation may be used to fight cancer in the near future

Inflammation may be used to fight cancer in the near future

New approach to cancer vaccines successful in early studies

New approach to cancer vaccines successful in early studies

B lymphocytes are deficient in nuclear excision repair and can accumulate mutations

B lymphocytes are deficient in nuclear excision repair and can accumulate mutations

EHA 2011: Lack of public research money endangers patients' care - European blood specialists raise the alarm

EHA 2011: Lack of public research money endangers patients' care - European blood specialists raise the alarm

Chemokine CCL2 recruits inflammatory monocytes to facilitate breast tumour metastasis

Chemokine CCL2 recruits inflammatory monocytes to facilitate breast tumour metastasis

Addition of cetuximab to oxaliplatin-based chemotherapy in advanced colorectal cancer: Results from the COIN trial

Addition of cetuximab to oxaliplatin-based chemotherapy in advanced colorectal cancer: Results from the COIN trial

ASCO 2011: High-dose chemo regimen improves survival in children with hard-to-treat neuroblastoma

ASCO 2011: High-dose chemo regimen improves survival in children with hard-to-treat neuroblastoma

More from ecancer